MITA says appropriate use criteria is best way to ensure appropriate and cost-effective medical imaging uilization

Washington, D.C. – The Medical Imaging & Technology Alliance (MITA) today reiterated the importance of physician-developed appropriate use criteria (AUC) to guide utilization of advanced medical imaging modalities in response to a JAMA Internal Medicine article that compiled a list of “low value” medical imaging procedures. “When used appropriately, medical imaging saves lives and prevents costly, invasive procedures down the road,” said Gail Rodriguez, executive director of MITA. “A thoughtful, evidence-based approach, rooted in AUC, is the best way to safeguard access and guide medical imaging utilization in a way that is tailored to each patient’s unique medical condition.” MITA endorses the use of physician-developed AUC to guide treatment decisions and training of personnel who perform medical imaging exams to ensure safe and effective use in every setting. ###
The Medical Imaging & Technology Alliance (MITA), a division of NEMA, is the collective voice of medical imaging equipment, radiation therapy and radiopharmaceutical manufacturers, innovators and product developers. It represents companies whose sales comprise more than 90 percent of the global market for medical imaging and radiation therapy technologies. For more information, visit www.medicalimaging.org. Follow MITA on Twitter @MITAToday.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.